PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   


Catalogue
Number
Product Order number / Unit

2810 N-Methylnaltrindole 2810.0005: 5 mg per vial
2810.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.

 
Reference standard for N1′([11C]Methyl)-naltrindole
Highly selective antagonist for δ opioid receptors
Molar Mass: 428.52
C27H28N2O3
[111555-57-8]
Yellowish solid packaged in dark glass screw cap vials.
Purity: > 95 %
Certificates:
CoA; 1H and 13C NMR spectra
Chemical Name:
CA index name: 4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a (9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-14-methyl-, (4bS,8R,8aS,14bR)-
Synonymes:
MeNTI; 4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a (9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-14-methyl-, [8R- (4bS, 8.α., 8a.beta., 14b.beta.)]; (5R,9R,13S,14S)-17-(cyclopropylmethyl)-6,7-dehydro-4,5.α.-epoxy-3,14-dihydroxy-N1′-methyl-6,7,2′,3′-indolomorphinan
Literature:
Madar I. et al. Imaging of δ- and μ-Opioid Receptors in Temporal Lobe Epilepsy by Positron Emission Tomography. Annals of Neurology 1997, 41, 358-367.
Lever J.R. et al. Synthesis of N1′-([11C]methyl)naltrindole ([11C]MeNTI): A radioligand for positron emission tomographic studies of δ opioid receptors. J. Labelled Compd. Radiopharm. 1995, 36, 137-145.
date of product catalogue issue: 10 May 2017

 
 
 

  PDF file       product list       home page       search       email       legal notice